Rosen Steven H 的 Form 4 申報
Invacare Holdings CorpIVC,2022/11/21 申報
- 申報編號
- 0000899243-22-036592
- 申報時間
- 2022/11/21 21:59 ET
- 交易日
- 2022/11/17-11/21
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄(2023 年以前)
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $4.82 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Rosen Steven HCIK 0001535144 | 董事、其他:Group member formerly over 10% |
| Azurite Management LLCCIK 0001933086 | 其他:Group member formerly over 10% |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F1
The price reported in column 4 is a weighted average price. These common shares, no par value (the "Common Shares"), were sold in multiple transactions at prices ranging from $0.460 to $0.462, inclusive. The Reporting Persons undertake to provide to Invacare Corporation (the "Issuer"), any securityholder of the Issuer or the staff of the Securities and Exchange Commission ("SEC Staff"), upon request, full information regarding the number of shares sold at each price within the range specified herein.
表 I 有 1 筆交易的價格引用這則附註。
- F2
The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $0.370 to $0.410, inclusive. The Reporting Persons undertake to provide to the Issuer, any securityholder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This Form 4 is being filed as a result of sales of Common Shares by Azurite. The sales were effected at prices below the prices of the purchases reported in the Form 4s filed by the Reporting Persons on June 7, 2022 (as amended on June 8, 2022) and June 27, 2022, such that there is no profit for purposes of Section 16(b) and the rules promulgated thereunder.
表 I 有 2 筆交易的價格引用這則附註。
- F5
Represents Mr. Rosen's voluntary return to the Issuer for no consideration of outstanding restricted stock units ("RSUs"), which were previously granted to him as a member of the Issuer's board of directors on August 22, 2022 (as reported on his Form 4 on August 24, 2022). Mr. Edward V. Crawford, another member of the Issuer's board of directors, also simultaneously returned the same number of RSUs for no consideration (as reported on his separate Form 4). The returns were approved by the Issuer's board of directors under Rule 16b-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
表 I 有 1 筆交易的價格引用這則附註。
- F6
The sales of the Common Shares and the returns of RSUs by Messrs. Rosen and Crawford were carried out to ensure the group of which the Reporting Persons are members (including Mr. Rosen, Azurite, Crawford United Corporation ("Crawford United"), Edward F. Crawford and Matthew V. Crawford, and collectively, the "Group")) collectively beneficially own less than 10% of the Issuer's total voting power. The Group members undertook these transactions promptly upon their discovery that the Group may have inadvertently become subject to Section 1704 of the Ohio Revised Code when previously exceeding 10% of the Issuer's total voting power. Following this slight reduction in the Group's ownership, Mr. Rosen and Mr. Crawford continue to serve as members of the Issuer's board of directors.
表 I 有 3 筆交易的價格引用這則附註。
備註
As described above, the Reporting Persons (Mr. Rosen and Azurite), along with Crawford United, Edward F. Crawford and Matthew V. Crawford, comprise a group within the meaning of Section 13(d)(3) of the Exchange Act. Crawford United and Messrs. Crawford separately own Common Shares of the Issuer. The Reporting Persons disclaim beneficial ownership over the Common Shares separately owned by Crawford United and Messrs. Crawford and any other Common Shares owned by the Group, except to the extent of their respective pecuniary interest therein.